Literature DB >> 33456767

The role of exogenous epidermal growth factor on Ki-67 proliferation marker expression in the submandibular salivary gland of albino rats receiving doxorubicin.

Mohamed Mansy1, Malak Soliman2, Rabab Mubarak3, Mohamed Shamel4.   

Abstract

Background: This study was conducted to evaluate the role of exogenous epidermal growth factor (EGF) injection on the Ki-67 immuno-expression in submandibular salivary gland tissue of rats receiving doxorubicin (DXR).
Methods: A total of 21 two-month-old male albino rats, of 200 g body weight, were divided into three groups: control group; DXR group, the rats received 20 mg/kg body weight DXR as a single intra peritoneal injection; DXR+EGF group, the rats received the same dose of DXR and on the next day they were injected intraperitoneally with 10 µg/kg body weight of EGF daily for one week. Histological sections and immunohistochemical expression of Ki67 sections were examined using a ZEISS Primo Star light microscopy and images taken using Tucsen IS 1000 10.0MP Camera.
Results: Ki-67 expression was significantly increased in submandibular salivary glands of rats after DXR injection. However, Ki-67 expression in the glandular tissue was restored to normal levels after EGF injection. Conclusions: EGF preserved glandular architecture after DXR injection and maintained Ki-67 immune-expression within the glandular tissue near to the normal level. Copyright:
© 2020 Mansy M et al.

Entities:  

Keywords:  Doxorubicin; Epidermal growth factor; Ki-67; submandibular salivary gland

Mesh:

Substances:

Year:  2020        PMID: 33456767      PMCID: PMC7797936          DOI: 10.12688/f1000research.27186.1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  40 in total

1.  Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.

Authors:  Franz Faul; Edgar Erdfelder; Axel Buchner; Albert-Georg Lang
Journal:  Behav Res Methods       Date:  2009-11

Review 2.  Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?

Authors:  S S Bielack; R Erttmann; B Kempf-Bielack; K Winkler
Journal:  Eur J Cancer       Date:  1996-09       Impact factor: 9.162

3.  Effect of local application of epidermal growth factor on innate immunity and cell composition of destruction focus in experimental thermal injury.

Authors:  M V Osikov; L F Telesheva; A G Likhacheva
Journal:  Bull Exp Biol Med       Date:  2014-07-29       Impact factor: 0.804

4.  The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis.

Authors:  Jyotirmoy Ghosh; Joydeep Das; Prasenjit Manna; Parames C Sil
Journal:  Biomaterials       Date:  2011-04-12       Impact factor: 12.479

5.  The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats.

Authors:  S Y Saad; T A Najjar; A C Al-Rikabi
Journal:  Pharmacol Res       Date:  2001-03       Impact factor: 7.658

6.  The cell cycle associated change of the Ki-67 reactive nuclear antigen expression.

Authors:  K Sasaki; T Murakami; M Kawasaki; M Takahashi
Journal:  J Cell Physiol       Date:  1987-12       Impact factor: 6.384

7.  Protein synthesis rate measured with L-[1-11C]tyrosine positron emission tomography correlates with mitotic activity and MIB-1 antibody-detected proliferation in human soft tissue sarcomas.

Authors:  B Plaat; A Kole; M Mastik; H Hoekstra; W Molenaar; W Vaalburg
Journal:  Eur J Nucl Med       Date:  1999-04

8.  Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage.

Authors:  Jorge Berlanga; Pedro Prats; Diadelis Remirez; Ricardo Gonzalez; Pedro Lopez-Saura; Jorge Aguiar; Miriam Ojeda; Joseph J Boyle; Anthony J Fitzgerald; Raymond J Playford
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Ki-67 and p53 immunostaining assessment of proliferative activity in salivary tumors.

Authors:  Alexandra Corina Faur; Ioan Sas; Andrei Gheorghe Marius Motoc; Mărioara Cornianu; Carmen Lăcrămioara Zamfir; Daniela Cornelia Lazăr; Roxana Folescu
Journal:  Rom J Morphol Embryol       Date:  2015       Impact factor: 1.033

10.  In vitro study on the effect of doxorubicin on the proliferation markers MCM3 and Ki-67.

Authors:  S Etemad-Moghadam; S Fouladdel; E Azizi; M Alaeddini
Journal:  J BUON       Date:  2013 Oct-Dec       Impact factor: 2.533

View more
  2 in total

1.  Effects of 4-hexylresorcinol administration on the submandibular glands in a growing rat model.

Authors:  Joo-Hyung Yoon; Dae-Won Kim; Suk Keun Lee; Seong-Gon Kim
Journal:  Head Face Med       Date:  2022-06-06       Impact factor: 2.246

2.  Attenuating Effect of Vitamin E against Silver Nano Particles Toxicity in Submandibular Salivary Glands.

Authors:  Mahmoud M Bakr; Mahmoud M Al-Ankily; Sara M Shogaa; Mohamed Shamel
Journal:  Bioengineering (Basel)       Date:  2021-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.